Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 23 Lymphoma, Large B-Cell, Diffuse 17 Recurrence 7 Neoplasms, Plasma Cell 5 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Mantle-Cell 4 Leukemia, Myeloid, Acute 4 Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, B-Cell 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Paraproteinemias 2 Neoplasms by Histologic Type 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2 Hematologic Diseases 2 Colorectal Neoplasms 2 Blood Protein Disorders 2 Sezary Syndrome 1 Renal Insufficiency 1 Neuroblastoma 1 Mycosis Fungoides 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

Cyclophosphamide 12 Vincristine 10 Radiotherapy 10 Carboplatin 10 Cisplatin 8 Melphalan 7 Etoposide 7 3-Iodobenzylguanidine 7 Isotretinoin 6 Filgrastim 6 Doxorubicin 6 aldesleukin 4 Peripheral Blood Stem Cell Transplantation 4 Busulfan 4 etoposide phosphate 3 Topotecan 3 Neoadjuvant Therapy 3 Interleukin-2 3 Ifosfamide 3 fludarabine 2 dinutuximab 2 Vindesine 2 Polymerase Chain Reaction 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Dacarbazine 2 Chemotherapy, Adjuvant 2 sargramostim 1 irinotecan sucrosofate 1 ganglioside, GD2 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neuroblastoma × Lenalidomide × Clear all

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡